Latest news

• Pfizer, BioNTech eye US approval for COVID-19 booster dose

  Pfizer and BioNTech will seek a new authorisation for a third booster dose of their COVID-19 vaccine from the US Food and Drug Administration according to reports. ... However, even if the booster dose is approved, it may not immediately mean that

• COVID-19 booster dose programme planned for September launch in Britain

  The JCVI’s interim advice is that, should a booster programme be required, a third COVID-19 vaccine dose should be offered to the most vulnerable first, starting from September 2021 ... Although the booster programme has not been finalised, government

• Study finds mixed vaccine schedules provide strong immune response against COVID-19

  marketed as Vaxzevria in the EU – induced strong immune responses following a delayed second dose interval of up to 45 weeks or after a third booster dose. ... The researchers also found that a third dose of Vaxzevria, administered at least six months

• J&J's single-dose COVID-19 vaccine secures approval from the UK’s MHRA

  efficacy as the third dose in a potential booster programme.